FreeIn the Archives Rainer Storb: Six decades of bone marrow transplant breakthroughs“His CV has more pages than almost any of you have papers.” September 05, 2025Vol.51 No.32
Conversation with The Cancer LetterFreePodcast Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSUBrian Druker returns to executive role as president of the new Knight Cancer Group August 14, 2025Vol.51 No.32By Paul Goldberg and Sara Willa Ernst
FreePodcastThe Directors The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five statesHonoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party” August 08, 2025Vol.51 No.31By Paul Goldberg
FreeGuest Editorial Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and lossHer collection, “To See Yourself As You Vanish,” will be published three years after her death August 08, 2025Vol.51 No.31By Angus (Gus) Reid
FreeGuest Editorial Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust August 08, 2025Vol.51 No.31By Louis M. Weiner
Book ReviewFree When public service ends abruptly, do books provide solace? An escape? Perspective?Former NIH and FDA employees tell us what they are reading in 2025 August 08, 2025Vol.51 No.31By Sara Willa Ernst
Capitol Hill GOP-led Congress rejects Trump’s plans to gut medical researchSenate bill gives NIH a $400 million raise August 01, 2025Vol.51 No.30By Paul Goldberg
News Analysis Vinay Prasad falls from grace at FDA upon flunking Trump political purity testMAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? August 01, 2025Vol.51 No.30By Claire Marie Porter
U.S. News & World Report expands evaluation of outcomes in cancer subspecialties August 01, 2025Vol.51 No.30By Sara Willa Ernst
Guest Editorial USPSTF doesn’t lean right or left—it’s about data, not politics August 01, 2025Vol.51 No.30By Barnett Kramer
